{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-044529","form_type":"8-K","ticker":"SIGY","cik":"0001642159","company_name":"Sigyn Therapeutics, Inc.","filed_at":"2023-12-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.914439+00:00","generated_at":"2026-06-07T14:14:58.220716+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Sigyn Therapeutics removes CFO Jeremy Ferrell, appoints Jerry DeCiccio as replacement","bullets":["Jeremy Ferrell removed as CFO effective immediately; no disagreements cited.","Jerry DeCiccio appointed CFO effective immediately; he is a CPA with 40+ years experience.","DeCiccio most recently served as a consultant; holds BA from Loma Linda and MBA from USC."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-044529","json":"https://secwatch.observer/filing/0001493152-23-044529.json","markdown":"https://secwatch.observer/filing/0001493152-23-044529.md","text":"https://secwatch.observer/filing/0001493152-23-044529.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642159/000149315223044529/0001493152-23-044529-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642159/000149315223044529/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T14:14:58.220716+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5a1e7bfa68","claim":"Jeremy Ferrell was removed as Chief Financial Officer at Sigyn Therapeutics, Inc..","evidence_excerpt":"the Company removed Jeremy Ferrell from his position as CFO of the Company, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1642159/000149315223044529/0001493152-23-044529-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"removed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"69446c0e47","claim":"Jerry DeCiccio was appointed as Chief Financial Officer at Sigyn Therapeutics, Inc..","evidence_excerpt":"The Company has appointed Jerry DeCiccio to serve as the Chief Financial Officer of the Company, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1642159/000149315223044529/0001493152-23-044529-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}